Pain News and Research

Latest Pain News and Research

Low levels of oxygen, nitric oxide appear to have unfortunate synergy for patients with sickle cell disease

Low levels of both oxygen and the powerful blood vessel dilator nitric oxide appear to have an unfortunate synergy for patients with sickle cell disease, researchers report.

21 Mar 2014

Elsevier launches Open Access, online-only journal Internet Interventions

Elsevier, a world-leading provider of scientific, technical and medical (STM) information products and services, is pleased to announce the launch of the Open Access, online-only journal Internet Interventions.

20 Mar 2014

Horizon Pharma secures $250 million in acquisition financing from Deerfield Management

Deerfield Management Company announced today that it has provided up to $250 million in acquisition financing to Horizon Pharma, Inc. for the acquisition of Vidara Therapeutics International Ltd.

19 Mar 2014

Majority of individuals leave decision to computer than to their business partner

When individuals engage in risky business transactions with each other, they may end up being disappointed. This is why they'd rather leave the decision on how to divvy up jointly-owned monies to a computer than to their business partner.

19 Mar 2014

Viewpoints: NRA shouldn't derail Surgeon General nominee; Democrats need to stand up for health law

The National Rifle Association has mounted an outrageous campaign to torpedo President Obama's nomination of an outstanding young doctor to be the next surgeon general of the United States because of his attitudes on gun control.

19 Mar 2014

Scientist receives SFI Saint Patrick's Day Science Medal from the prime minister of Ireland

Enda Kenny, the prime minister of Ireland, presented Garret A. FitzGerald, MD, FRS, director of the Institute for Translational Medicine and Therapeutics and chair of the Department of Pharmacology, Perelman School of Medicine, University of Pennsylvania, with the inaugural St. Patrick's Day Science Medal at an Science Foundation Ireland (SFI)-hosted event in Washington D.C. last week.

19 Mar 2014

Medivir announces phase III ATTAIN study of simeprevir inhibitor in treatment of adult patients with HCV

Medivir AB today announced that new phase III data for the once-daily protease inhibitor simeprevir have been presented at the Conference of the Asian Pacific Association for the Study of the Liver (APASL) in Brisbane, Australia.

19 Mar 2014

Kessler Foundation receives grant to supports variety of rehabilitation research projects in spinal cord injury

Kessler Foundation has received more than $718,000 in grant funding from the Craig Neilsen Foundation. The funding, comprised of five grants, supports a variety of rehabilitation research projects in spinal cord injury (SCI), including pain management, functional outcomes, quality of life, and factors affecting cognitive function.

18 Mar 2014

Study estimates a third of uninsured won't enroll in health plans

The Fiscal Times reports that the study by Bankrate.com shows government outreach efforts are falling short. Meanwhile, news outlets look at enrollment efforts in New Jersey, Montana, Maine, Washington, Pennsylvania, Ohio and California.

18 Mar 2014

Over 40% of pregnant low-income women after diagnosis of false labor do not want to be sent home

More than 40 percent of pregnant low-income women discharged from the hospital after a diagnosis of false or early labor did not want to be sent home, with the most common reasons being that they were in too much pain or lived too far away, according to a study by Baylor University's Louise Herrington School of Nursing (LHSON) and Parkland Health & Hospital System.

18 Mar 2014

Prescriptions of opioid analgesics increased during U.S. emergency department visits

George Washington University (GW) researchers report dramatic increases in prescriptions of opioid analgesics, such as Percocet, Vicodin, oxycodone and Dilaudid, during U.S. emergency department visits from 2001 to 2010.

18 Mar 2014

Study: Men are more likely to receive faster care for heart attacks and angina than women

A new study indicates that in younger adults experiencing heart attacks and angina, men are more likely to receive faster care compared with women. The study, published in CMAJ (Canadian Medical Association Journal) also found that gender-related factors affected access to care for both men and women.

18 Mar 2014

Ocular Therapeutix starts Phase 3 clinical program to evaluate safety, efficacy of dexamethasone

Ocular Therapeutix, Inc. announces the start of its Phase 3 clinical program to evaluate the safety and efficacy of their sustained release dexamethasone, an ophthalmic corticosteroid for the treatment of post-operative inflammation and pain following cataract surgery. Ocular Therapeutix's dexamethasone is administered as a one-time, bioabsorbable intracanalicular plug for release of the steroid to the ocular surface for up 30 days.

18 Mar 2014

Antibe Therapeutics completes pre-clinical program for its lead product ATB-346

Antibe Therapeutics Inc. ("Antibe" or the "Corporation") is pleased to announce that it has completed its planned pre-clinical program for its lead product ATB-346 to support initial clinical studies in humans.

17 Mar 2014

First Edition: March 17, 2014

Today's headlines include reports about new health coverage rules and guidances announced by the Obama administration.

17 Mar 2014

Binghamton University plays role in improving Rwandan’s healthcare system

Twenty years after the Rwandan Genocide left nearly 1 million dead and 2 million homeless, Binghamton University is playing a role in improving the nation's healthcare. Karen Feltham, a clinical instructor in the Decker School of Nursing, spent the 2013 fall semester in Rwanda working with women in the Rwandan Midwives Association.

17 Mar 2014

Study finds that patients who lose weight have better joint replacement outcomes

While many overweight patients have the best intentions to lose weight after joint replacement, a study at Hospital for Special Surgery (HSS) finds that although some are able to achieve this goal, equal numbers of patients actually gain weight after hip or knee replacement.

17 Mar 2014

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration approved a Supplemental New Drug Application (sNDA) for Eliquis (apixaban) for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery.

16 Mar 2014

PRP injections provide short- and long-term pain relief for patients with severe chronic hip bursitis

Chronic hip bursitis is a common yet difficult condition to treat successfully. A recent study, presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons, compared the results of PRP and cortisone injections in patients with severe chronic hip (greater trochanteric) bursitis.

14 Mar 2014

Study finds higher readmission rates for same-day total joint replacement surgery

As the effectiveness of anesthesia, pain management and rehabilitation continues to improve, more orthopaedic procedures are being done on an outpatient basis. In a new research study presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons, same-day total joint replacement (TJR) patient outcomes were comparable to those of patients admitted to the hospital and staying at least one night following surgery.

14 Mar 2014

Pain News and Research

Latest Pain News and Research

Low levels of oxygen, nitric oxide appear to have unfortunate synergy for patients with sickle cell disease

Elsevier launches Open Access, online-only journal Internet Interventions

Horizon Pharma secures $250 million in acquisition financing from Deerfield Management

Majority of individuals leave decision to computer than to their business partner

Viewpoints: NRA shouldn't derail Surgeon General nominee; Democrats need to stand up for health law

Scientist receives SFI Saint Patrick's Day Science Medal from the prime minister of Ireland

Medivir announces phase III ATTAIN study of simeprevir inhibitor in treatment of adult patients with HCV

Kessler Foundation receives grant to supports variety of rehabilitation research projects in spinal cord injury

Study estimates a third of uninsured won't enroll in health plans

Over 40% of pregnant low-income women after diagnosis of false labor do not want to be sent home

Prescriptions of opioid analgesics increased during U.S. emergency department visits

Study: Men are more likely to receive faster care for heart attacks and angina than women

Ocular Therapeutix starts Phase 3 clinical program to evaluate safety, efficacy of dexamethasone

Antibe Therapeutics completes pre-clinical program for its lead product ATB-346

First Edition: March 17, 2014

Binghamton University plays role in improving Rwandan’s healthcare system

Study finds that patients who lose weight have better joint replacement outcomes

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

PRP injections provide short- and long-term pain relief for patients with severe chronic hip bursitis

Study finds higher readmission rates for same-day total joint replacement surgery

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Pain News and Research

Latest Pain News and Research

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in